About Capri-Medical
Capri-Medical is a company based in Dublin (Ireland) founded in 2018 by Fergal Ward. Capri-Medical offers products and services including Injectable Neurostimulation Device, Wireless Power Platform, and Advanced Therapy Procedure. Capri-Medical operates in a competitive market with competitors including Route 92 Medical, Autonomix, Balt, Shenzhen Weiling Medical Equipment Co and Neuro Front, among others.
- Headquarter Dublin, Ireland
- Founders Fergal Ward
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$55.74 K (USD), Grant
Jan 31, 2022
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Capri-Medical
Capri-Medical offers a comprehensive portfolio of products and services, including Injectable Neurostimulation Device, Wireless Power Platform, and Advanced Therapy Procedure.
Provides minimally invasive therapy for neurostimulation treatments.
Delivers next-generation wireless power for medical applications.
Offers simple injectable procedures for patient treatment access.
Funding Insights of Capri-Medical
Investors in Capri-Medical
Capri-Medical has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Capri-Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Capri-Medical
Investment portfolio details for Capri-Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Capri-Medical
Detailed financials for Capri-Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Capri-Medical Comparisons
Peer comparison for Capri-Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Capri-Medical
Capri-Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Route 92 Medical, Autonomix, Balt, Shenzhen Weiling Medical Equipment Co and Neuro Front, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation products for neurointerventional procedures are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive neural monitoring and treatment devices are developed.
|
|
| Locked | Locked | Locked |
Interventional neuroradiology devices for vascular malformations are developed.
|
|
| Locked | Locked | Locked |
Implantable wireless brain-computer interfaces are developed for neural signal analysis.
|
|
| Locked | Locked | Locked |
Transformation medicines and neuromodulation devices for neurological disorders are developed.
|
Detailed competitors of Capri-Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Capri-Medical
Complete news archive for Capri-Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Capri-Medical
Capri-Medical was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Capri-Medical is headquartered in Dublin, Ireland.
Fergal Ward is the current CEO of Capri-Medical. They have also founded this company.
Capri-Medical was founded in 2018 in Dublin, Ireland, within the medical technology sector. Injectable devices are developed by the company to address chronic neurological conditions through minimally invasive neurostimulation delivery. Operations center on creating targeted therapeutic solutions for neurology, with a focus on device innovation and clinical applicability in the European market. Leadership is provided by founder Fergal Ward as CEO.
Capri-Medical's top competitors include Route 92 Medical, Autonomix and Magnendo.
Capri-Medical offers Injectable Neurostimulation Device, Wireless Power Platform, and Advanced Therapy Procedure.
Capri-Medical has 2 investors. Key investors include European Union, and EIC Fund.